These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17786542)

  • 1. Macrophage migration inhibitory factor does not modulate co-activation of androgen receptor by Jab1/CSN5.
    Berndt K; Kim M; Meinhardt A; Klug J
    Mol Cell Biochem; 2008 Jan; 307(1-2):265-71. PubMed ID: 17786542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity.
    Lue H; Thiele M; Franz J; Dahl E; Speckgens S; Leng L; Fingerle-Rowson G; Bucala R; Lüscher B; Bernhagen J
    Oncogene; 2007 Aug; 26(35):5046-59. PubMed ID: 17310986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1.
    Kleemann R; Hausser A; Geiger G; Mischke R; Burger-Kentischer A; Flieger O; Johannes FJ; Roger T; Calandra T; Kapurniotu A; Grell M; Finkelmeier D; Brunner H; Bernhagen J
    Nature; 2000 Nov; 408(6809):211-6. PubMed ID: 11089976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity.
    Lue H; Kapurniotu A; Fingerle-Rowson G; Roger T; Leng L; Thiele M; Calandra T; Bucala R; Bernhagen J
    Cell Signal; 2006 May; 18(5):688-703. PubMed ID: 16122907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor binding and cellular uptake studies of macrophage migration inhibitory factor (MIF): use of biologically active labeled MIF derivatives.
    Kleemann R; Grell M; Mischke R; Zimmermann G; Bernhagen J
    J Interferon Cytokine Res; 2002 Mar; 22(3):351-63. PubMed ID: 12034043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of JAB1/CSN5 to MIF is mediated by the MPN domain but is independent of the JAMM motif.
    Burger-Kentischer A; Finkelmeier D; Thiele M; Schmucker J; Geiger G; Tovar GE; Bernhagen J
    FEBS Lett; 2005 Mar; 579(7):1693-701. PubMed ID: 15757663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural characterization of As-MIF and hJAB1 during the inhibition of cell-cycle regulation.
    Park YH; Jeong MS; Ha KT; Yu HS; Jang SB
    BMB Rep; 2017 May; 50(5):269-274. PubMed ID: 28366190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIF1α-Induced by Lysophosphatidic Acid Is Stabilized via Interaction with MIF and CSN5.
    No YR; Lee SJ; Kumar A; Yun CC
    PLoS One; 2015; 10(9):e0137513. PubMed ID: 26352431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JAB1/CSN5 and the COP9 signalosome. A complex situation.
    Chamovitz DA; Segal D
    EMBO Rep; 2001 Feb; 2(2):96-101. PubMed ID: 11258719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stat3 contributes to cancer progression by regulating Jab1/Csn5 expression.
    Pan Y; Wang S; Su B; Zhou F; Zhang R; Xu T; Zhang R; Leventaki V; Drakos E; Liu W; Claret FX
    Oncogene; 2017 Feb; 36(8):1069-1079. PubMed ID: 27524414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSN5/Jab1 inhibits cardiac L-type Ca2+ channel activity through protein-protein interactions.
    Kameda K; Fukao M; Kobayashi T; Tsutsuura M; Nagashima M; Yamada Y; Yamashita T; Tohse N
    J Mol Cell Cardiol; 2006 Apr; 40(4):562-9. PubMed ID: 16483597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired DNA damage checkpoint response in MIF-deficient mice.
    Nemajerova A; Mena P; Fingerle-Rowson G; Moll UM; Petrenko O
    EMBO J; 2007 Feb; 26(4):987-97. PubMed ID: 17290223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fank1 interacts with Jab1 and regulates cell apoptosis via the AP-1 pathway.
    Wang H; Song W; Hu T; Zhang N; Miao S; Zong S; Wang L
    Cell Mol Life Sci; 2011 Jun; 68(12):2129-39. PubMed ID: 20978819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The emerging roles of Jab1/CSN5 in cancer.
    Wang L; Zheng JN; Pei DS
    Med Oncol; 2016 Aug; 33(8):90. PubMed ID: 27412572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage migration inhibitory factor directly interacts with hepatopoietin and regulates the proliferation of hepatoma cell.
    Li Y; Lu C; Xing G; Zhu Y; He F
    Exp Cell Res; 2004 Nov; 300(2):379-87. PubMed ID: 15475002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JAB1/CSN5 interacts with the GAL4 DNA binding domain: a note of caution about two-hybrid interactions.
    Nordgård O; Dahle Ø; Andersen TØ; Gabrielsen OS
    Biochimie; 2001 Oct; 83(10):969-71. PubMed ID: 11728635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSN5/Jab1 controls multiple events in the mammalian cell cycle.
    Yoshida A; Yoneda-Kato N; Panattoni M; Pardi R; Kato JY
    FEBS Lett; 2010 Nov; 584(22):4545-52. PubMed ID: 20974137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex dimorphism in wound healing: the roles of sex steroids and macrophage migration inhibitory factor.
    Gilliver SC; Ruckshanthi JP; Hardman MJ; Nakayama T; Ashcroft GS
    Endocrinology; 2008 Nov; 149(11):5747-57. PubMed ID: 18653719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplification of tumor hypoxic responses by macrophage migration inhibitory factor-dependent hypoxia-inducible factor stabilization.
    Winner M; Koong AC; Rendon BE; Zundel W; Mitchell RA
    Cancer Res; 2007 Jan; 67(1):186-93. PubMed ID: 17210698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSN5/Jab1 is involved in ligand-dependent degradation of estrogen receptor {alpha} by the proteasome.
    Calligé M; Kieffer I; Richard-Foy H
    Mol Cell Biol; 2005 Jun; 25(11):4349-58. PubMed ID: 15899841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.